AMGN vs NRXPW · P/E 24, rev $10.05B vs rev $242.0K
Amgen Inc (AMGN) versus NRx Pharmaceuticals Inc (NRXPW) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
NRx Pharmaceuticals Inc (NRXPW) common stock listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported NRXPW revenue for 2025-09-30 was $242.0K. Net income was -$5.9M. NRXPW currently screens at market cap $714.6M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. NRXPW currently screens at market cap $714.6M.
Not investment advice. Open the AMGN and NRXPW stock pages for the full models.
Not investment advice.